NM_001710.6:c.1036+111A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001710.6(CFB):​c.1036+111A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.684 in 1,558,018 control chromosomes in the GnomAD database, including 370,930 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 40872 hom., cov: 31)
Exomes 𝑓: 0.68 ( 330058 hom. )

Consequence

CFB
NM_001710.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.00600

Publications

72 publications found
Variant links:
Genes affected
CFB (HGNC:1037): (complement factor B) This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while Ba inhibits their proliferation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. This cluster includes several genes involved in regulation of the immune reaction. Polymorphisms in this gene are associated with a reduced risk of age-related macular degeneration. The polyadenylation site of this gene is 421 bp from the 5' end of the gene for complement component 2. [provided by RefSeq, Jul 2008]
CFB Gene-Disease associations (from GenCC):
  • atypical hemolytic-uremic syndrome with B factor anomaly
    Inheritance: Unknown, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • complement factor b deficiency
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 6-31948623-A-G is Benign according to our data. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.84 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CFBNM_001710.6 linkc.1036+111A>G intron_variant Intron 7 of 17 ENST00000425368.7 NP_001701.2 P00751-1A0A1U9X7H8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CFBENST00000425368.7 linkc.1036+111A>G intron_variant Intron 7 of 17 1 NM_001710.6 ENSP00000416561.2 P00751-1
ENSG00000244255ENST00000456570.5 linkc.2542+111A>G intron_variant Intron 19 of 29 2 ENSP00000410815.1 B4E1Z4

Frequencies

GnomAD3 genomes
AF:
0.728
AC:
110561
AN:
151928
Hom.:
40834
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.815
Gnomad AMI
AF:
0.753
Gnomad AMR
AF:
0.716
Gnomad ASJ
AF:
0.888
Gnomad EAS
AF:
0.587
Gnomad SAS
AF:
0.863
Gnomad FIN
AF:
0.702
Gnomad MID
AF:
0.908
Gnomad NFE
AF:
0.671
Gnomad OTH
AF:
0.781
GnomAD4 exome
AF:
0.679
AC:
955050
AN:
1405972
Hom.:
330058
AF XY:
0.688
AC XY:
482739
AN XY:
701636
show subpopulations
African (AFR)
AF:
0.829
AC:
27010
AN:
32598
American (AMR)
AF:
0.709
AC:
31010
AN:
43710
Ashkenazi Jewish (ASJ)
AF:
0.888
AC:
22868
AN:
25754
East Asian (EAS)
AF:
0.645
AC:
25418
AN:
39388
South Asian (SAS)
AF:
0.879
AC:
74377
AN:
84600
European-Finnish (FIN)
AF:
0.685
AC:
31086
AN:
45412
Middle Eastern (MID)
AF:
0.895
AC:
4821
AN:
5384
European-Non Finnish (NFE)
AF:
0.652
AC:
697928
AN:
1070478
Other (OTH)
AF:
0.691
AC:
40532
AN:
58648
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
16174
32348
48523
64697
80871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18042
36084
54126
72168
90210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.728
AC:
110653
AN:
152046
Hom.:
40872
Cov.:
31
AF XY:
0.731
AC XY:
54340
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.816
AC:
33827
AN:
41476
American (AMR)
AF:
0.715
AC:
10930
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.888
AC:
3083
AN:
3472
East Asian (EAS)
AF:
0.589
AC:
3035
AN:
5156
South Asian (SAS)
AF:
0.862
AC:
4152
AN:
4816
European-Finnish (FIN)
AF:
0.702
AC:
7416
AN:
10564
Middle Eastern (MID)
AF:
0.905
AC:
266
AN:
294
European-Non Finnish (NFE)
AF:
0.671
AC:
45619
AN:
67968
Other (OTH)
AF:
0.777
AC:
1640
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1493
2985
4478
5970
7463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.693
Hom.:
152062
Bravo
AF:
0.733
Asia WGS
AF:
0.702
AC:
2441
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
3.3
DANN
Benign
0.61
PhyloP100
-0.0060
PromoterAI
0.033
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs537160; hg19: chr6-31916400; COSMIC: COSV54961796; COSMIC: COSV54961796; API